Laboratory Co. of America (NYSE:LH – Get Free Report) and Many Bright Ideas Technologies (OTCMKTS:MBGNF – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.
This is a breakdown of recent recommendations for Laboratory Co. of America and Many Bright Ideas Technologies, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Laboratory Co. of America||0||2||7||0||2.78|
|Many Bright Ideas Technologies||0||0||0||0||N/A|
Laboratory Co. of America presently has a consensus target price of $251.75, suggesting a potential upside of 23.14%. Given Laboratory Co. of America’s higher possible upside, equities research analysts plainly believe Laboratory Co. of America is more favorable than Many Bright Ideas Technologies.
|Net Margins||Return on Equity||Return on Assets|
|Laboratory Co. of America||5.89%||14.62%||7.38%|
|Many Bright Ideas Technologies||N/A||N/A||N/A|
Insider & Institutional Ownership
89.4% of Laboratory Co. of America shares are held by institutional investors. 0.7% of Laboratory Co. of America shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Laboratory Co. of America and Many Bright Ideas Technologies’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Laboratory Co. of America||$14.88 billion||1.22||$1.28 billion||$9.27||22.06|
|Many Bright Ideas Technologies||N/A||N/A||N/A||N/A||N/A|
Laboratory Co. of America has higher revenue and earnings than Many Bright Ideas Technologies.
Laboratory Co. of America beats Many Bright Ideas Technologies on 8 of the 8 factors compared between the two stocks.
About Laboratory Co. of America
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
About Many Bright Ideas Technologies
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.